Minimal improvement in coronary artery disease risk prediction in Chinese population using polygenic risk scores: evidence from the China Kadoorie Biobank

BACKGROUND Several studies have reported that polygenic risk scores (PRSs) can enhance risk prediction of coronary artery disease (CAD) in European populations. However, research on this topic is far from sufficient in non-European countries, including China. We aimed to evaluate the potential of PRS for predicting CAD for primary prevention in the Chinese population. METHODS Participants with genome-wide genotypic data from the China Kadoorie Biobank were divided into training (n = 28,490) and testing sets (n = 72,150). Ten previously developed PRSs were evaluated, and new ones were developed using clumping and thresholding or LDpred method. The PRS showing the strongest association with CAD in the training set was selected to further evaluate its effects on improving the traditional CAD risk-prediction model in the testing set. Genetic risk was computed by summing the product of the weights and allele dosages across genome-wide single-nucleotide polymorphisms. Prediction of the 10-year first CAD events was assessed using hazard ratios (HRs) and measures of model discrimination, calibration, and net reclassification improvement (NRI). Hard CAD (nonfatal I21-I23 and fatal I20-I25) and soft CAD (all fatal or nonfatal I20-I25) were analyzed separately. RESULTS In the testing set, 1214 hard and 7201 soft CAD cases were documented during a mean follow-up of 11.2 years. The HR per standard deviation of the optimal PRS was 1.26 (95% CI:1.19-1.33) for hard CAD. Based on a traditional CAD risk prediction model containing only non-laboratory-based information, the addition of PRS for hard CAD increased Harrell's C index by 0.001 (-0.001 to 0.003) in women and 0.003 (0.001 to 0.005) in men. Among the different high-risk thresholds ranging from 1% to 10%, the highest categorical NRI was 3.2% (95% CI: 0.4-6.0%) at a high-risk threshold of 10.0% in women. The association of the PRS with soft CAD was much weaker than with hard CAD, leading to minimal or no improvement in the soft CAD model. CONCLUSIONS In this Chinese population sample, the current PRSs minimally changed risk discrimination and offered little to no improvement in risk stratification for soft CAD. Therefore, this may not be suitable for promoting genetic screening in the general Chinese population to improve CAD risk prediction.

[1]  Xueli Yang,et al.  Temporal trend in mortality of cardiovascular diseases and its contribution to life expectancy increase in China, 2013 to 2018 , 2022, Chinese medical journal.

[2]  Hao Wang,et al.  Development of a Model to Predict 10-Year Risk of Ischemic and Hemorrhagic Stroke and Ischemic Heart Disease Using the China Kadoorie Biobank , 2022, Neurology.

[3]  M. Pirinen,et al.  Integration of questionnaire-based risk factors improves polygenic risk scores for human coronary heart disease and type 2 diabetes , 2022, Communications biology.

[4]  M. Inouye,et al.  Prognostic Value of a Polygenic Risk Score for Coronary Heart Disease in Individuals Aged 70 Years and Older , 2021, Circulation. Genomic and precision medicine.

[5]  J. Danesh,et al.  SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. , 2021, European heart journal.

[6]  C. Gieger,et al.  Comparison of genetic risk prediction models to improve prediction of coronary heart disease in two large cohorts of the MONICA/KORA study , 2021, Genetic epidemiology.

[7]  L. Liang,et al.  A large-scale genome-wide association analysis of lung function in the Chinese population identifies novel loci and highlights shared genetic aetiology with obesity , 2021, European Respiratory Journal.

[8]  P. Donnelly,et al.  Integrated Polygenic Tool Substantially Enhances Coronary Artery Disease Prediction , 2021, Circulation. Genomic and precision medicine.

[9]  Hongyu Zhao,et al.  Interactions between Enhanced Polygenic Risk Scores and Lifestyle for Cardiovascular Disease, Diabetes Mellitus and Lipid Levels. , 2021, Circulation. Genomic and precision medicine.

[10]  J. Danesh,et al.  Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses , 2021, PLoS medicine.

[11]  H. Aburatani,et al.  Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease , 2020, Nature Genetics.

[12]  A. Khera,et al.  Genome-Wide Polygenic Score, Clinical Risk Factors, and Long-Term Trajectories of Coronary Artery Disease , 2020, Arteriosclerosis, thrombosis, and vascular biology.

[13]  J. Danesh,et al.  Validation of a Genome-Wide Polygenic Score for Coronary Artery Disease in South Asians. , 2020, Journal of the American College of Cardiology.

[14]  S. A. Lambert,et al.  The Polygenic Score Catalog: an open database for reproducibility and systematic evaluation , 2020, medRxiv.

[15]  Marc S. Williams,et al.  Predictive Utility of Polygenic Risk Scores for Coronary Heart Disease in Three Major Racial and Ethnic Groups. , 2020, American journal of human genetics.

[16]  Audrey Y. Chu,et al.  Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers , 2020, Nature Medicine.

[17]  C. Robinson-Cohen,et al.  Predictive Accuracy of a Polygenic Risk Score Compared With a Clinical Risk Score for Incident Coronary Heart Disease. , 2020, JAMA.

[18]  P. Elliott,et al.  Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease. , 2020, JAMA.

[19]  Gretchen A. Stevens,et al.  World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions , 2019, The Lancet. Global health.

[20]  S. Harikrishnan,et al.  Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. , 2018, Lancet.

[21]  P. Donnelly,et al.  The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.

[22]  J. Danesh,et al.  Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults , 2018, Journal of the American College of Cardiology.

[23]  Mary E. Haas,et al.  Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations , 2018, Nature Genetics.

[24]  Pim van der Harst,et al.  Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease , 2017, Circulation research.

[25]  L. Qi,et al.  Adherence to Healthy Lifestyle and Cardiovascular Diseases in the Chinese Population. , 2017, Journal of the American College of Cardiology.

[26]  C. Iribarren,et al.  Clinical Utility of Multimarker Genetic Risk Scores for Prediction of Incident Coronary Heart Disease: A Cohort Study Among Over 51 000 Individuals of European Ancestry , 2016, Circulation. Cardiovascular genetics.

[27]  Xueli Yang,et al.  Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China) , 2016, Circulation.

[28]  L. Wain,et al.  Haplotype estimation for biobank scale datasets , 2016, Nature Genetics.

[29]  Markus Perola,et al.  Genomic prediction of coronary heart disease , 2016, bioRxiv.

[30]  P. Visscher,et al.  Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores , 2015, bioRxiv.

[31]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[32]  Sebastian M. Armasu,et al.  A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease , 2015, Nature Genetics.

[33]  Diane Lacaille,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk , 2014 .

[34]  V. Salomaa,et al.  Genetic Risk Prediction and a 2-Stage Risk Screening Strategy for Coronary Heart Disease , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[35]  R. Collins,et al.  China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. , 2011, International journal of epidemiology.

[36]  Sharon R Grossman,et al.  Integrating common and rare genetic variation in diverse human populations , 2010, Nature.

[37]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[38]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[39]  OUP accepted manuscript , 2022, European Heart Journal.